{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:02:01Z","timestamp":1793746921983,"version":"4.6.1"},"reference-count":234,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>Renal cell carcinoma (RCC) subtypes are increasingly being discerned via their molecular underpinnings. Frequently this can be correlated to histologic and immunohistochemical surrogates, such that only simple targeted molecular assays, or none at all, are needed for diagnostic confirmation. In clear cell RCC, <jats:italic toggle=\"yes\">VHL<\/jats:italic> mutation and 3p loss are well known; however, other genes with emerging important roles include <jats:italic toggle=\"yes\">SETD2<\/jats:italic>, <jats:italic toggle=\"yes\">BAP1<\/jats:italic>, and <jats:italic toggle=\"yes\">PBRM1<\/jats:italic>, among others. Papillary RCC type 2 is now known to include likely several different molecular entities, such as fumarate hydratase (FH) deficient RCC. In MIT family translocation RCC, an increasing number of gene fusions are now described. Some <jats:italic toggle=\"yes\">TFE3<\/jats:italic> fusion partners, such as <jats:italic toggle=\"yes\">NONO<\/jats:italic>, <jats:italic toggle=\"yes\">GRIPAP1<\/jats:italic>, <jats:italic toggle=\"yes\">RBMX<\/jats:italic>, and <jats:italic toggle=\"yes\">RBM10<\/jats:italic> may show a deceptive fluorescence in situ hybridization result due to the proximity of the genes on the same chromosome. FH and succinate dehydrogenase deficient RCC have implications for patient counseling due to heritable syndromes and the aggressiveness of FH-deficient RCC. Immunohistochemistry is increasingly available and helpful for recognizing both. Emerging tumor types with strong evidence for distinct diagnostic entities include eosinophilic solid and cystic RCC and <jats:italic toggle=\"yes\">TFEB<\/jats:italic>\/<jats:italic toggle=\"yes\">VEGFA<\/jats:italic>\/6p21 amplified RCC. Other emerging entities that are less clearly understood include <jats:italic toggle=\"yes\">TCEB1<\/jats:italic> mutated RCC, RCC with <jats:italic toggle=\"yes\">ALK<\/jats:italic> rearrangement, renal neoplasms with mutations of <jats:italic toggle=\"yes\">TSC2<\/jats:italic> or <jats:italic toggle=\"yes\">MTOR<\/jats:italic>, and RCC with fibromuscular stroma. In metastatic RCC, the role of molecular studies is not entirely defined at present, although there may be an increasing role for genomic analysis related to specific therapy pathways, such as for tyrosine kinase or MTOR inhibitors.<\/jats:p>","DOI":"10.1097\/pas.0000000000001476","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T18:51:23Z","timestamp":1586199083000},"page":"e47-e65","source":"Crossref","is-referenced-by-count":99,"title":["Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers"],"prefix":"10.1097","volume":"44","author":[{"given":"Sean R.","family":"Williamson","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System"},{"name":"Department of Pathology, Wayne State University School of Medicine, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[{"name":"NSW Health Pathology, Department of Anatomical Pathology"},{"name":"Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards"},{"name":"Sydney Medical School, University of Sydney, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Argani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Bei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Egevad","sequence":"additional","affiliation":[{"name":"Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Kristiansen","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Grignon","sequence":"additional","affiliation":[{"name":"Department of Pathology, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Hes","sequence":"additional","affiliation":[{"name":"Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Pilsen, Czechia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4,3]]},"reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1200\/JCO.2012.45.2003","article-title":"Molecular genetics of clear-cell renal cell carcinoma","volume":"32","author":"Brugarolas","year":"2014","journal-title":"J Clin Oncol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.eururo.2019.06.015","article-title":"Familial Kidney Cancer: implications of new syndromes and molecular insights","volume":"76","author":"Carlo","year":"2019","journal-title":"Eur Urol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","article-title":"The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia","volume":"37","author":"Srigley","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","year":"2013","journal-title":"Nature"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ng.2699","article-title":"Integrated molecular analysis of clear-cell renal cell carcinoma","volume":"45","author":"Sato","year":"2013","journal-title":"Nat Genet"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.celrep.2016.02.024","article-title":"Multilevel genomics-based taxonomy of renal cell carcinoma","volume":"14","author":"Chen","year":"2016","journal-title":"Cell Rep"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5858\/arpa.2019-0134-RA","article-title":"Practical molecular testing in a clinical genitourinary service","volume":"144","author":"Magers","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PAS.0000000000000776","article-title":"Renal cell carcinoma with chromosome 6p amplification including the TFEB gene: a novel mechanism of tumor pathogenesis?","volume":"41","author":"Williamson","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.juro.2010.09.013","article-title":"Pathological, immunohistochemical and cytogenetic features of papillary renal cell carcinoma with clear cell features","volume":"185","author":"Klatte","year":"2011","journal-title":"J Urol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"13131","DOI":"10.1038\/ncomms13131","article-title":"Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets","volume":"7","author":"Chen","year":"2016","journal-title":"Nat Commun"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/modpathol.2017.72","article-title":"Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database","volume":"30","author":"Favazza","year":"2017","journal-title":"Mod Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/14737159.2015.1068122","article-title":"BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies","volume":"15","author":"Piva","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/PAS.0b013e31821e25cd","article-title":"Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study","volume":"35","author":"Al-Ahmadie","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/PAS.0b013e3181570343","article-title":"Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing 2 antibodies","volume":"32","author":"Al-Ahmadie","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2559.2011.04074.x","article-title":"Expression of carbonic anhydrase IX in genitourinary and adrenal tumours","volume":"59","author":"Donato","year":"2011","journal-title":"Histopathology"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1309\/AJCPPPR57HNJMSLZ","article-title":"Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade","volume":"134","author":"Genega","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2010.03.015","article-title":"Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy","volume":"58","author":"Stillebroer","year":"2010","journal-title":"Eur Urol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1158\/1078-0432.CCR-13-2868","article-title":"Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors","volume":"20","author":"Feldman","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/modpathol.2011.80","article-title":"Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins","volume":"24","author":"Rohan","year":"2011","journal-title":"Mod Pathol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.anndiagpath.2017.11.004","article-title":"Chromosomal numerical aberration pattern in papillary renal cell carcinoma: review article","volume":"40","author":"Pitra","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Linehan","year":"2016","journal-title":"N Engl J Med"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1097\/PAS.0000000000000962","article-title":"Toward biological subtyping of papillary renal cell carcinoma with clinical implications through histologic, immunohistochemical, and molecular analysis","volume":"41","author":"Saleeb","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.urolonc.2017.07.022","article-title":"Commentary on: \u201cComprehensive molecular characterization of papillary renal-cell carcinoma.\u201d Cancer Genome Atlas Research Network","volume":"35","author":"Lee","year":"2017","journal-title":"Urol Oncol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-5347(17)35015-2","article-title":"Hereditary papillary renal cell carcinoma","volume":"151","author":"Zbar","year":"1994","journal-title":"J Urol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat Genet"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2174\/1566524043359674","article-title":"Hereditary papillary renal carcinoma type I","volume":"4","author":"Dharmawardana","year":"2004","journal-title":"Curr Mol Med"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/PAP.0000000000000220","article-title":"Papillary renal cell carcinoma (PRCC): an update","volume":"26","author":"Akhtar","year":"2019","journal-title":"Adv Anat Pathol"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9440(10)65147-4","article-title":"Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype","volume":"155","author":"Lubensky","year":"1999","journal-title":"Am J Pathol"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/KCA-190058","article-title":"A review of papillary renal cell carcinoma and MET inhibitors","volume":"3","author":"Rhoades Smith","year":"2019","journal-title":"Kidney Cancer"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejca.2017.10.014","article-title":"Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial","volume":"87","author":"Schoffski","year":"2017","journal-title":"Eur J Cancer"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.1016\/S1470-2045(17)30508-9","article-title":"Savolitinib for MET-driven papillary renal cell carcinoma","volume":"18","author":"Gilbert","year":"2017","journal-title":"Lancet Oncol"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1158\/1078-0432.CCR-14-0690","article-title":"MET as a target in papillary renal cell carcinoma","volume":"20","author":"Fay","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2012.43.3383","article-title":"Phase II and biomarker study of the dual MET\/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma","volume":"31","author":"Choueiri","year":"2013","journal-title":"J Clin Oncol"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/01.pas.0000184821.09871.ec","article-title":"Adult papillary renal tumor with oncocytic cells: clinicopathologic, immunohistochemical, and cytogenetic features of 10 cases","volume":"29","author":"Lefevre","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prp.2016.04.009","article-title":"Oncocytic papillary renal cell carcinoma: a clinicopathological and genetic analysis and indolent clinical course in 14 cases","volume":"213","author":"Han","year":"2017","journal-title":"Pathol Res Pract"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.humpath.2007.05.016","article-title":"Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features","volume":"39","author":"Kunju","year":"2008","journal-title":"Hum Pathol"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.anndiagpath.2005.12.002","article-title":"Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases","volume":"10","author":"Hes","year":"2006","journal-title":"Ann Diagn Pathol"},{"key":"R42-20230922","article-title":"Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity","author":"Al-Obaidy","year":"2019","journal-title":"Mod Pathol"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/PAS.0000000000001288","article-title":"Papillary renal neoplasm with reverse polarity: a morphologic, immunohistochemical, and molecular study","volume":"43","author":"Al-Obaidy","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R44-20230922","doi-asserted-by":"crossref","DOI":"10.1111\/his.14084","article-title":"Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei","author":"Tong","year":"2020","journal-title":"Histopathology"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.humpath.2017.03.004","article-title":"Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists","volume":"63","author":"Williamson","year":"2017","journal-title":"Hum Pathol"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1464-410X.2008.08263.x","article-title":"Hybrid tumour \u2018oncocytoma-chromophobe renal cell carcinoma\u2019 of the kidney: a report of seven sporadic cases","volume":"103","author":"Delongchamps","year":"2009","journal-title":"BJU Int"},{"key":"R47-20230922","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00428-010-0898-4","article-title":"Sporadic hybrid oncocytic\/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases","volume":"456","author":"Petersson","year":"2010","journal-title":"Virchows Arch"},{"key":"R48-20230922","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/00000478-199909000-00013","article-title":"Renal oncocytosis: a morphologic study of fourteen cases","volume":"23","author":"Tickoo","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"R49-20230922","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/PAS.0b013e3181d73293","article-title":"Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles","volume":"34","author":"Gobbo","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R50-20230922","first-page":"356","article-title":"Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization","volume":"145","author":"Speicher","year":"1994","journal-title":"Am J Pathol"},{"key":"R52-20230922","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"key":"R53-20230922","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/gcc.20805","article-title":"Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies","volume":"49","author":"Vieira","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"R54-20230922","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00428-013-1457-6","article-title":"Chromophobe renal cell carcinoma\u2014chromosomal aberration variability and its relation to Paner grading system: an array CGH and FISH analysis of 37 cases","volume":"463","author":"Sperga","year":"2013","journal-title":"Virchows Arch"},{"key":"R55-20230922","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1471-2407-10-196","article-title":"Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma","volume":"10","author":"Tan","year":"2010","journal-title":"BMC Cancer"},{"key":"R56-20230922","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.celrep.2015.10.059","article-title":"The genomic landscape of renal oncocytoma identifies a metabolic barrier to tumorigenesis","volume":"13","author":"Joshi","year":"2015","journal-title":"Cell Rep"},{"key":"R57-20230922","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1309\/AJCP9HDXYB2WYYJX","article-title":"Telangiectatic oncocytoma: a previously undescribed variant of renal oncocytoma","volume":"140","author":"Xiao","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"R58-20230922","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/PAI.0000000000000156","article-title":"Cystic renal oncocytoma and tubulocystic renal cell carcinoma: morphologic and immunohistochemical comparative study","volume":"24","author":"Skenderi","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R59-20230922","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/106689690100900307","article-title":"Small cell variant of renal oncocytoma\u2014a rare and misleading type of benign renal tumor","volume":"9","author":"Hes","year":"2001","journal-title":"Int J Surg Pathol"},{"key":"R60-20230922","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/pin.12410","article-title":"Renal oncocytoma, small cell variant, with pseudorosettes, showing cyclin D1 expression and tubulovesicular cristae of mitochondria","volume":"66","author":"Kuroda","year":"2016","journal-title":"Pathol Int"},{"key":"R61-20230922","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00428-005-0114-0","article-title":"Small-cell variant of renal oncocytoma with dominating solid growth pattern: a potential diagnostic pitfall","volume":"448","author":"Magro","year":"2006","journal-title":"Virchows Arch"},{"key":"R62-20230922","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.humpath.2011.01.022","article-title":"Renal small cell oncocytoma with pseudorosettes A histomorphologic, immunohistochemical, and molecular genetic study of 10 cases","volume":"42","author":"Petersson","year":"2011","journal-title":"Hum Pathol"},{"key":"R63-20230922","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.acthis.2014.11.013","article-title":"The clinicopathological, ultrastructural, genetic features and diagnosis of small cell variant renal oncocytoma","volume":"117","author":"Zhang","year":"2015","journal-title":"Acta Histochem"},{"key":"R64-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15586\/jkcvhl.2017.96","article-title":"Modern pathologic diagnosis of renal oncocytoma","volume":"4","author":"Wobker","year":"2017","journal-title":"J Kidney Cancer VHL"},{"key":"R66-20230922","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.5858\/2007-131-1782-VRIROI","article-title":"Vimentin reactivity in renal oncocytoma: immunohistochemical study of 234 cases","volume":"131","author":"Hes","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"R67-20230922","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-4608(92)90372-F","article-title":"Cytogenetic analysis of six renal oncocytomas and a chromophobe cell renal carcinoma. Evidence that -Y, -1 may be a characteristic anomaly in renal oncocytomas","volume":"61","author":"Crotty","year":"1992","journal-title":"Cancer Genet Cytogenet"},{"key":"R68-20230922","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0022-5347(17)32766-0","article-title":"Renal oncocytoma with a translocation t(9;11)(p23;q13)","volume":"152","author":"Fuzesi","year":"1994","journal-title":"J Urol"},{"key":"R69-20230922","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5858\/2007-131-81-HIOCAI","article-title":"High incidence of chromosome 1 abnormalities in a series of 27 renal oncocytomas: cytogenetic and fluorescence in situ hybridization studies","volume":"131","author":"Paner","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"R70-20230922","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/01.ju.0000109172.07081.16","article-title":"Cytogenetic analysis of a series of 13 renal oncocytomas","volume":"171","author":"Lindgren","year":"2004","journal-title":"J Urol"},{"key":"R71-20230922","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1309\/KC2465ANDWVAXYDM","article-title":"Analysis of chromosome 1p abnormalities in renal oncocytomas by loss of heterozygosity studies: correlation with conventional cytogenetics and fluorescence in situ hybridization","volume":"129","author":"Picken","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"R72-20230922","article-title":"Cytogenetic analysis of 130 renal oncocytomas identify three distinct and mutually exclusive diagnostic classes of chromosome aberrations","author":"Anderson","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"key":"R73-20230922","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.humpath.2009.01.016","article-title":"CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma","volume":"40","author":"Sukov","year":"2009","journal-title":"Hum Pathol"},{"key":"R74-20230922","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.pas.0000185382.80844.b1","article-title":"Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia","volume":"30","author":"Tickoo","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R75-20230922","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1365-2559.2011.03857.x","article-title":"Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases","volume":"58","author":"Adam","year":"2011","journal-title":"Histopathology"},{"key":"R76-20230922","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/PAS.0000000000000446","article-title":"Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor","volume":"39","author":"Aron","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R77-20230922","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1097\/PAS.0b013e3181f2ee0b","article-title":"Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney","volume":"34","author":"Aydin","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R78-20230922","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/PAS.0000000000000456","article-title":"Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma","volume":"39","author":"Deml","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R79-20230922","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/PAS.0000000000000513","article-title":"Do clear cell papillary renal cell carcinomas have malignant potential?","volume":"39","author":"Diolombi","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R80-20230922","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/his.12359","article-title":"Clear cell papillary renal cell carcinoma is an indolent and low-grade neoplasm with overexpression of cyclin-D1","volume":"64","author":"Leroy","year":"2014","journal-title":"Histopathology"},{"key":"R82-20230922","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/modpathol.2012.204","article-title":"Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile","volume":"26","author":"Williamson","year":"2013","journal-title":"Mod Pathol"},{"key":"R83-20230922","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.humpath.2013.08.004","article-title":"Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma","volume":"45","author":"Zhou","year":"2014","journal-title":"Hum Pathol"},{"key":"R84-20230922","first-page":"241A","article-title":"GATA\u00ad3 is a specific marker for clear cell papillary renal cell carcinoma","volume":"30","author":"Mantilla","year":"2017","journal-title":"Mod Pathol"},{"key":"R85-20230922","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pathol.2016.05.014","article-title":"Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker","volume":"49","author":"Martignoni","year":"2017","journal-title":"Pathology"},{"key":"R86-20230922","first-page":"370","article-title":"A molecular profile of clear cell papillary renal cell carcinoma by next generation sequencing","volume":"31","author":"Morlote","year":"2018","journal-title":"Mod Pathol"},{"key":"R87-20230922","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38986","article-title":"Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma","volume":"8","author":"Xu","year":"2019","journal-title":"Elife"},{"key":"R88-20230922","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/modpathol.2013.140","article-title":"Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma","volume":"27","author":"Fisher","year":"2014","journal-title":"Mod Pathol"},{"key":"R89-20230922","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1349-7006.2011.02176.x","article-title":"Genomic profiling of renal cell carcinoma in patients with end-stage renal disease","volume":"103","author":"Inoue","year":"2012","journal-title":"Cancer Sci"},{"key":"R90-20230922","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.humpath.2014.01.013","article-title":"Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma","volume":"45","author":"Munari","year":"2014","journal-title":"Hum Pathol"},{"key":"R91-20230922","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00428-011-1137-3","article-title":"Clonal trisomies 7,10 and 12, normal 3p and absence of VHL gene mutation in a clear cell tubulopapillary carcinoma of the kidney","volume":"459","author":"Wolfe","year":"2011","journal-title":"Virchows Arch"},{"key":"R92-20230922","doi-asserted-by":"crossref","first-page":"292.e17","DOI":"10.1016\/j.urolonc.2016.01.001","article-title":"Clear cell renal cell tumors: not all that is \u201cclear\u201d is cancer","volume":"34","author":"Williamson","year":"2016","journal-title":"Urol Oncol"},{"key":"R93-20230922","doi-asserted-by":"crossref","DOI":"10.1111\/his.14071","article-title":"Defining clear cell papillary renal cell carcinoma in routine clinical practice","author":"Gupta","year":"2020","journal-title":"Histopathology"},{"key":"R94-20230922","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/PAS.0000000000000514","article-title":"Clear cell renal cell carcinoma with borderline features of clear cell papillary renal cell carcinoma: combined morphologic, immunohistochemical, and cytogenetic analysis","volume":"39","author":"Williamson","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R95-20230922","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PAS.0000000000000583","article-title":"Renal neoplasms with overlapping features of clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma: a clinicopathologic study of 37 cases from a single institution","volume":"40","author":"Dhakal","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R96-20230922","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/PAS.0b013e318282dab8","article-title":"Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma","volume":"37","author":"Williamson","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R97-20230922","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/j.semdp.2015.02.003","article-title":"MiT family translocation renal cell carcinoma","volume":"32","author":"Argani","year":"2015","journal-title":"Semin Diagn Pathol"},{"key":"R98-20230922","first-page":"125","article-title":"MiT family translocation renal cell carcinomas: a 15th anniversary update","volume":"35","author":"Gandhi","year":"2020","journal-title":"Histol Histopathol"},{"key":"R99-20230922","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0002-9440(10)61684-7","article-title":"Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents","volume":"159","author":"Argani","year":"2001","journal-title":"Am J Pathol"},{"key":"R100-20230922","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1038\/sj.onc.1206686","article-title":"A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23)","volume":"22","author":"Argani","year":"2003","journal-title":"Oncogene"},{"key":"R102-20230922","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/PAS.0b013e318031ffff","article-title":"Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum","volume":"31","author":"Argani","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R103-20230922","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/PAS.0b013e3181e8ce5b","article-title":"Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers","volume":"34","author":"Argani","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R104-20230922","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/modpathol.2013.208","article-title":"Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage","volume":"27","author":"Ellis","year":"2014","journal-title":"Mod Pathol"},{"key":"R105-20230922","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0000000000000631","article-title":"TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R106-20230922","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1158\/1078-0432.CCR-13-3036","article-title":"Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes","volume":"20","author":"Malouf","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R107-20230922","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/S0002-9440(10)64680-9","article-title":"A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation","volume":"158","author":"Argani","year":"2001","journal-title":"Am J Pathol"},{"key":"R108-20230922","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/PAS.0000000000001307","article-title":"TFEB expression profiling in renal cell carcinomas: clinicopathologic correlations","volume":"43","author":"Gupta","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R109-20230922","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/modpathol.2017.24","article-title":"TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management","volume":"30","author":"Gupta","year":"2017","journal-title":"Mod Pathol"},{"key":"R110-20230922","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/modpathol.2017.99","article-title":"Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays","volume":"31","author":"Skala","year":"2018","journal-title":"Mod Pathol"},{"key":"R111-20230922","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.anndiagpath.2014.10.002","article-title":"Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature","volume":"18","author":"Peckova","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"R112-20230922","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng.3146","article-title":"Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes","volume":"47","author":"Durinck","year":"2015","journal-title":"Nat Genet"},{"key":"R113-20230922","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/his.13439","article-title":"Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH","volume":"72","author":"Xia","year":"2018","journal-title":"Histopathology"},{"key":"R114-20230922","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/PAS.0b013e3181609914","article-title":"Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature","volume":"32","author":"Camparo","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R115-20230922","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/modpathol.2011.93","article-title":"Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions","volume":"24","author":"Martignoni","year":"2011","journal-title":"Mod Pathol"},{"key":"R116-20230922","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/modpathol.2009.58","article-title":"Cathepsin-K immunoreactivity distinguishes MiTF\/TFE family renal translocation carcinomas from other renal carcinomas","volume":"22","author":"Martignoni","year":"2009","journal-title":"Mod Pathol"},{"key":"R117-20230922","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1097\/PAS.0b013e3182613d8f","article-title":"Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum","volume":"36","author":"Argani","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R118-20230922","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/PAS.0b013e31828a69ae","article-title":"Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service","volume":"37","author":"Green","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R119-20230922","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/PAS.0b013e31827e17cb","article-title":"TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum","volume":"37","author":"Rao","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R120-20230922","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/modpathol.2016.204","article-title":"Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement","volume":"30","author":"Xia","year":"2017","journal-title":"Mod Pathol"},{"key":"R121-20230922","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/PAS.0000000000000835","article-title":"RBM10-TFE3 renal cell carcinoma: a potential diagnostic pitfall due to cryptic intrachromosomal Xp11.2 inversion resulting in false-negative TFE3 FISH","volume":"41","author":"Argani","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R122-20230922","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/gcc.22356","article-title":"Identification by FFPE RNA-Seq of a new recurrent inversion leading to RBM10-TFE3 fusion in renal cell carcinoma with subtle TFE3 break-apart FISH pattern","volume":"55","author":"Just","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"R123-20230922","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/PAS.0000000000000837","article-title":"Xp11 translocation renal cell carcinomas (RCCs) with RBM10-TFE3 gene fusion demonstrating melanotic features and overlapping morphology with t(6;11) RCC: interest and diagnostic pitfall in detecting a paracentric inversion of TFE3","volume":"41","author":"Xia","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R124-20230922","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/his.13167","article-title":"Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas","volume":"70","author":"Classe","year":"2017","journal-title":"Histopathology"},{"key":"R125-20230922","article-title":"A novel RBMX-TFE3 gene fusion in a highly aggressive pediatric renal perivascular epithelioid cell tumor","author":"Argani","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"key":"R126-20230922","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/PAS.0000000000001000","article-title":"Reappraisal of morphologic differences between renal medullary carcinoma, collecting duct carcinoma, and fumarate hydratase-deficient renal cell carcinoma","volume":"42","author":"Ohe","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R127-20230922","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41379-019-0273-1","article-title":"Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases","volume":"32","author":"Jia","year":"2019","journal-title":"Mod Pathol"},{"key":"R128-20230922","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.eururo.2015.09.027","article-title":"Balanced translocations disrupting SMARCB1 are hallmark recurrent genetic alterations in renal medullary carcinomas","volume":"69","author":"Calderaro","year":"2016","journal-title":"Eur Urol"},{"key":"R129-20230922","doi-asserted-by":"crossref","first-page":"e987","DOI":"10.1016\/j.clgc.2017.04.012","article-title":"Genomic characterization of renal medullary carcinoma and treatment outcomes","volume":"15","author":"Carlo","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"R130-20230922","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2559.2012.04228.x","article-title":"SMARCB1\/INI1 inactivation in renal medullary carcinoma","volume":"61","author":"Calderaro","year":"2012","journal-title":"Histopathology"},{"key":"R131-20230922","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/PAS.0b013e3182770406","article-title":"Renal medullary carcinoma: molecular, immunohistochemistry, and morphologic correlation","volume":"37","author":"Liu","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R132-20230922","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/modpathol.2008.44","article-title":"Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior","volume":"21","author":"Cheng","year":"2008","journal-title":"Mod Pathol"},{"key":"R133-20230922","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/PAS.0b013e3182417d78","article-title":"Expression of OCT3\/4 in renal medullary carcinoma represents a potential diagnostic pitfall","volume":"36","author":"Rao","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R134-20230922","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.humpath.2017.07.006","article-title":"Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma","volume":"67","author":"Sirohi","year":"2017","journal-title":"Hum Pathol"},{"key":"R135-20230922","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/PAS.0000000000000222","article-title":"Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity","volume":"38","author":"Amin","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R136-20230922","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.eururo.2015.06.019","article-title":"Characterization of clinical cases of collecting duct carcinoma of the kidney assessed by comprehensive genomic profiling","volume":"70","author":"Pal","year":"2016","journal-title":"Eur Urol"},{"key":"R137-20230922","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/00313020310001619929","article-title":"Mucinous tubular and spindle cell carcinoma and post-neuroblastoma carcinoma: newly recognised entities in the renal cell carcinoma family","volume":"35","author":"Eble","year":"2003","journal-title":"Pathology"},{"key":"R138-20230922","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.pas.0000180443.94645.50","article-title":"Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution","volume":"30","author":"Paner","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R139-20230922","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/PAS.0b013e3181872d3f","article-title":"Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma","volume":"33","author":"Amin","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R140-20230922","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1097\/PAS.0b013e3181be22d1","article-title":"Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification","volume":"33","author":"Zhou","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R141-20230922","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/his.12840","article-title":"Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma","volume":"68","author":"Tran","year":"2016","journal-title":"Histopathology"},{"key":"R142-20230922","first-page":"1215","article-title":"Review of acquired cystic disease-associated renal cell carcinoma with focus on pathobiological aspects","volume":"26","author":"Kuroda","year":"2011","journal-title":"Histol Histopathol"},{"key":"R144-20230922","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.anndiagpath.2011.04.001","article-title":"Metastatic renal mucinous tubular and spindle cell carcinoma. Atypical behavior of a rare, morphologically bland tumor","volume":"16","author":"Thway","year":"2012","journal-title":"Ann Diagn Pathol"},{"key":"R145-20230922","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/PAS.0b013e3181829ed5","article-title":"Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change","volume":"33","author":"Dhillon","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R146-20230922","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.humpath.2009.03.004","article-title":"Aggressive high-grade mucinous tubular and spindle cell carcinoma","volume":"40","author":"Bulimbasic","year":"2009","journal-title":"Hum Pathol"},{"key":"R147-20230922","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/PAS.0000000000001038","article-title":"Distinct genomic copy number alterations distinguish mucinous tubular and spindle cell carcinoma of the kidney from papillary renal cell carcinoma with overlapping histologic features","volume":"42","author":"Ren","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R148-20230922","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.anndiagpath.2015.04.004","article-title":"Mucinous spindle and tubular renal cell carcinoma: analysis of chromosomal aberration pattern of low-grade, high-grade, and overlapping morphologic variant with papillary renal cell carcinoma","volume":"19","author":"Peckova","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"R149-20230922","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/his.13298","article-title":"Chromosomal abnormalities of high-grade mucinous tubular and spindle cell carcinoma of the kidney","volume":"71","author":"Sadimin","year":"2017","journal-title":"Histopathology"},{"key":"R150-20230922","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/modpathol.3800565","article-title":"Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma","volume":"19","author":"Cossu-Rocca","year":"2006","journal-title":"Mod Pathol"},{"key":"R151-20230922","doi-asserted-by":"crossref","first-page":"268.e1","DOI":"10.1016\/j.clgc.2019.04.006","article-title":"Mucinous tubular and spindle-cell carcinoma of the kidney: clinical features, genomic profiles, and treatment outcomes","volume":"17","author":"Ged","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"R152-20230922","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1158\/2159-8290.CD-16-0267","article-title":"Biallelic alteration and dysregulation of the hippo pathway in mucinous tubular and spindle cell carcinoma of the kidney","volume":"6","author":"Mehra","year":"2016","journal-title":"Cancer Discov"},{"key":"R153-20230922","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/PAS.0000000000001150","article-title":"VSTM2A overexpression is a sensitive and specific biomarker for mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney","volume":"42","author":"Wang","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R154-20230922","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/PAS.0b013e318150df1d","article-title":"Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization","volume":"32","author":"Yang","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R155-20230922","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41379-018-0185-5","article-title":"Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile","volume":"32","author":"Sarungbam","year":"2019","journal-title":"Mod Pathol"},{"key":"R156-20230922","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/PAS.0b013e3181a13e7b","article-title":"Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney","volume":"33","author":"Osunkoya","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R157-20230922","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.humpath.2012.11.015","article-title":"Tubulocystic carcinoma of the kidney with poorly differentiated foci: a series of 3 cases with fluorescence in situ hybridization analysis","volume":"44","author":"Al-Hussain","year":"2013","journal-title":"Hum Pathol"},{"key":"R158-20230922","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000719","article-title":"Tubulocystic carcinoma of the kidney with poorly differentiated foci: a frequent morphologic pattern of fumarate hydratase-deficient renal cell carcinoma","volume":"40","author":"Smith","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R159-20230922","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00795-009-0465-8","article-title":"Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y","volume":"43","author":"Kuroda","year":"2010","journal-title":"Med Mol Morphol"},{"key":"R160-20230922","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.anndiagpath.2010.07.008","article-title":"Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features","volume":"15","author":"Kuroda","year":"2011","journal-title":"Ann Diagn Pathol"},{"key":"R161-20230922","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00795-010-0496-1","article-title":"Acquired cystic disease-associated renal cell carcinoma: an immunohistochemical and fluorescence in situ hybridization study","volume":"44","author":"Kuroda","year":"2011","journal-title":"Med Mol Morphol"},{"key":"R162-20230922","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/modpathol.3800604","article-title":"Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study","volume":"19","author":"Cossu-Rocca","year":"2006","journal-title":"Mod Pathol"},{"key":"R163-20230922","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.humpath.2009.09.022","article-title":"Oligoarray comparative genomic hybridization of renal cell tumors that developed in patients with acquired cystic renal disease","volume":"41","author":"Kuntz","year":"2010","journal-title":"Hum Pathol"},{"key":"R165-20230922","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/PCR.0000000000000023","article-title":"The pathology of von Hippel-Lindau disease","volume":"19","author":"Guo","year":"2014","journal-title":"Pathol Case Rev"},{"key":"R166-20230922","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1586\/era.10.72","article-title":"Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy","volume":"10","author":"Cheng","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"R167-20230922","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1200\/JCO.2013.50.8192","article-title":"Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management","volume":"32","author":"Shuch","year":"2014","journal-title":"J Clin Oncol"},{"key":"R168-20230922","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAT.0b013e3283539932","article-title":"Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia","volume":"44","author":"Gill","year":"2012","journal-title":"Pathology"},{"key":"R169-20230922","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/his.13277","article-title":"Succinate dehydrogenase (SDH)-deficient neoplasia","volume":"72","author":"Gill","year":"2018","journal-title":"Histopathology"},{"key":"R170-20230922","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.humpath.2009.12.005","article-title":"Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes","volume":"41","author":"Gill","year":"2010","journal-title":"Hum Pathol"},{"key":"R171-20230922","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S1470-2045(09)70164-0","article-title":"An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis","volume":"10","author":"Van Nederveen","year":"2009","journal-title":"Lancet Oncol"},{"key":"R172-20230922","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma","volume":"19","author":"Burnichon","year":"2010","journal-title":"Hum Mol Genet"},{"key":"R173-20230922","doi-asserted-by":"crossref","first-page":"E1472","DOI":"10.1210\/jc.2011-1043","article-title":"SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas","volume":"96","author":"Korpershoek","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R174-20230922","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jmedgenet-2018-105427","article-title":"Bayesian approach to determining penetrance of pathogenic SDH variants","volume":"55","author":"Benn","year":"2018","journal-title":"J Med Genet"},{"key":"R176-20230922","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMc1012357","article-title":"Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4","volume":"364","author":"Gill","year":"2011","journal-title":"N Engl J Med"},{"key":"R177-20230922","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e318227e7f4","article-title":"Renal tumors associated with germline SDHB mutation show distinctive morphology","volume":"35","author":"Gill","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R178-20230922","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1200\/JCO.2012.47.2647","article-title":"Renal carcinoma associated with succinate dehydrogenase B mutation: a new and unique subtype of renal carcinoma","volume":"32","author":"Paik","year":"2014","journal-title":"J Clin Oncol"},{"key":"R179-20230922","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","article-title":"Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R180-20230922","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/modpathol.2014.86","article-title":"Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma","volume":"28","author":"Williamson","year":"2015","journal-title":"Mod Pathol"},{"key":"R181-20230922","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/PAT.0000000000000018","article-title":"Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma","volume":"45","author":"Gill","year":"2013","journal-title":"Pathology"},{"key":"R182-20230922","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.humpath.2015.07.027","article-title":"Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma","volume":"46","author":"Ozluk","year":"2015","journal-title":"Hum Pathol"},{"key":"R183-20230922","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/PAS.0000000000000403","article-title":"A novel SDHA-deficient renal cell carcinoma revealed by comprehensive genomic profiling","volume":"39","author":"Yakirevich","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R184-20230922","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0000000000000573","article-title":"Fumarate hydratase-deficient uterine leiomyomas occur in both the syndromic and sporadic settings","volume":"40","author":"Harrison","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R185-20230922","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/his.13402","article-title":"Pathology and genetics of phaeochromocytoma and paraganglioma","volume":"72","author":"Turchini","year":"2018","journal-title":"Histopathology"},{"key":"R186-20230922","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/PAS.0000000000000617","article-title":"Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R187-20230922","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.anndiagpath.2019.02.008","article-title":"Fumarate hydratase deficient renal cell carcinoma: chromosomal numerical aberration analysis of 12 cases","volume":"39","author":"Pivovarcikova","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"R188-20230922","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/PAS.0000000000001372","article-title":"A clinicopathologic and molecular analysis of fumarate hydratase-deficient renal cell carcinoma in 32 patients","volume":"44","author":"Lau","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R189-20230922","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/cncy.22071","article-title":"Clues to recognition of fumarate hydratase-deficient renal cell carcinoma: findings from cytologic and limited biopsy samples","volume":"126","author":"Shyu","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"R190-20230922","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","volume":"38","author":"Chen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R191-20230922","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41379-018-0017-7","article-title":"Pattern multiplicity and fumarate hydratase (FH)\/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration","volume":"31","author":"Muller","year":"2018","journal-title":"Mod Pathol"},{"key":"R192-20230922","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/PAS.0000000000000703","article-title":"Fumarase-deficient uterine leiomyomas: an immunohistochemical, molecular genetic, and clinicopathologic study of 86 cases","volume":"40","author":"Miettinen","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R194-20230922","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000000562","article-title":"Hereditary renal cell carcinoma syndromes: clinical, pathologic, and genetic features","volume":"39","author":"Adeniran","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R195-20230922","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R196-20230922","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"38","author":"Yang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R197-20230922","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PAS.0000000000001170","article-title":"Somatic mutations of TSC2 or MTOR characterize a morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm","volume":"43","author":"Chen","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R198-20230922","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2018.06.007","article-title":"Somatic bi-allelic loss of TSC genes in eosinophilic solid and cystic renal cell carcinoma","volume":"74","author":"Mehra","year":"2018","journal-title":"Eur Urol"},{"key":"R199-20230922","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/PAS.0000000000001111","article-title":"Eosinophilic solid and cystic (ESC) renal cell carcinomas harbor TSC mutations: molecular analysis supports an expanding clinicopathologic spectrum","volume":"42","author":"Palsgrove","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R200-20230922","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/PAS.0000000000001067","article-title":"Are sporadic eosinophilic solid and cystic renal cell carcinomas characterized by somatic tuberous sclerosis gene mutations?","volume":"42","author":"Parilla","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R201-20230922","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0000000000000838","article-title":"Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a distinct entity","volume":"41","author":"Trpkov","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R202-20230922","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/PAS.0000000000000508","article-title":"Eosinophilic, solid, and cystic renal cell carcinoma: clinicopathologic study of 16 unique, sporadic neoplasms occurring in women","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R203-20230922","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2018.05.023","article-title":"Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases","volume":"80","author":"Tretiakova","year":"2018","journal-title":"Hum Pathol"},{"key":"R204-20230922","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/his.13395","article-title":"Re-evaluation of 33 \u2018unclassified\u2019 eosinophilic renal cell carcinomas in young patients","volume":"72","author":"Li","year":"2018","journal-title":"Histopathology"},{"key":"R205-20230922","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.pathol.2019.04.006","article-title":"Renal cell carcinomas with a mesenchymal stromal component: what do we know so far?","volume":"51","author":"Williamson","year":"2019","journal-title":"Pathology"},{"key":"R206-20230922","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/PAS.0000000000001255","article-title":"Genetic underpinnings of renal cell carcinoma with leiomyomatous stroma","volume":"43","author":"Parilla","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R207-20230922","first-page":"78","article-title":"Expanding the morphologic spectrum of sporadic renal cell carcinoma (RCC) harboring somatic TSC or MTOR alterations: analysis of 8 cases with clear cytoplasm and leiomyomatous stroma","volume":"32","author":"Jia","year":"2019","journal-title":"Mod Pathol"},{"key":"R208-20230922","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2017.11.013","article-title":"Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex","volume":"75","author":"Williamson","year":"2018","journal-title":"Hum Pathol"},{"key":"R209-20230922","first-page":"266A","article-title":"A clinico-pathologic study of 17 patients with renal cell carcinoma associated with leiomyomatous stroma identifies a strong association with tuberous sclerosis","volume":"95","author":"Verkarre","year":"2015","journal-title":"Lab Invest"},{"key":"R210-20230922","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00428-018-2456-4","article-title":"\u201cHigh-grade oncocytic renal tumor\u201d: morphologic, immunohistochemical, and molecular genetic study of 14 cases","volume":"473","author":"He","year":"2018","journal-title":"Virchows Arch"},{"key":"R211-20230922","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/his.13876","article-title":"High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complex","volume":"75","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"key":"R212-20230922","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/modpathol.2015.6","article-title":"TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype","volume":"28","author":"Hakimi","year":"2015","journal-title":"Mod Pathol"},{"key":"R213-20230922","first-page":"229A","article-title":"Renal cell carcinoma with monosomy 8 and CAIX expression: a distinct entity or another member or the clear cell tubulopapillary RCC\/RAT family?","volume":"28","author":"Hirsch","year":"2015","journal-title":"Mod Pathol"},{"key":"R214-20230922","article-title":"\u201cRenal cell carcinoma with leiomyomatous stroma\u201d harbor somatic mutations of TSC1, TSC2, MTOR, and\/or ELOC (TCEB1): clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity","author":"Shah","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R215-20230922","article-title":"Putative drivers of aggressiveness in TCEB1-mutant renal cell carcinoma: an emerging entity with variable clinical course","author":"DiNatale","year":"2019","journal-title":"Eur Urol Focus"},{"key":"R216-20230922","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/PAS.0000000000000720","article-title":"TFEB-amplified renal cell carcinomas: an aggressive molecular subset demonstrating variable melanocytic marker expression and morphologic heterogeneity","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R217-20230922","doi-asserted-by":"crossref","first-page":"494","DOI":"10.5858\/arpa.2018-0104-OA","article-title":"Clinical utility of chromosome genomic array testing for unclassified and advanced-stage renal cell carcinomas","volume":"143","author":"Andeen","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"R218-20230922","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/modpathol.2010.213","article-title":"Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum","volume":"24","author":"Debelenko","year":"2011","journal-title":"Mod Pathol"},{"key":"R219-20230922","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1002\/cncr.27391","article-title":"Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method","volume":"118","author":"Sugawara","year":"2012","journal-title":"Cancer"},{"key":"R220-20230922","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/modpathol.2012.107","article-title":"ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients","volume":"25","author":"Sukov","year":"2012","journal-title":"Mod Pathol"},{"key":"R221-20230922","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cancergen.2017.11.010","article-title":"ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review","volume":"221","author":"Bodokh","year":"2018","journal-title":"Cancer Genet"},{"key":"R222-20230922","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/gcc.22382","article-title":"Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: Identification of a novel HOOK1-ALK fusion transcript","volume":"55","author":"Cajaiba","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"R223-20230922","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/gcc.22346","article-title":"ALK-rearranged renal cell carcinomas in children","volume":"55","author":"Cajaiba","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"R224-20230922","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/modpathol.2012.144","article-title":"Distinct ALK-rearranged and VCL-negative papillary renal cell carcinoma variant in two adults without sickle cell trait","volume":"26","author":"Hodge","year":"2013","journal-title":"Mod Pathol"},{"key":"R225-20230922","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.prp.2016.07.015","article-title":"ALK rearrangements-associated renal cell carcinoma (RCC) with unique pathological features in an adult","volume":"212","author":"Jeanneau","year":"2016","journal-title":"Pathol Res Pract"},{"key":"R226-20230922","first-page":"85","article-title":"Clinicopathological study of seven cases of ALK-positive renal tumor identification of new fusion partners including CLIP1 and KIF5B genes","volume":"32","author":"Kuroda","year":"2019","journal-title":"Mod Pathol"},{"key":"R227-20230922","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5114\/pjp.2018.76693","article-title":"A review of ALK-rearranged renal cell carcinomas with a focus on clinical and pathobiological aspects","volume":"69","author":"Kuroda","year":"2018","journal-title":"Pol J Pathol"},{"key":"R228-20230922","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/PAS.0000000000000610","article-title":"Two cases of renal cell carcinoma harboring a novel STRN-ALK fusion gene","volume":"40","author":"Kusano","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R229-20230922","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4132\/KoreanJPathol.2013.47.5.452","article-title":"ALK-positive renal cell carcinoma in a large series of consecutively resected Korean renal cell carcinoma patients","volume":"47","author":"Lee","year":"2013","journal-title":"Korean J Pathol"},{"key":"R230-20230922","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/gcc.20839","article-title":"ALK rearrangement in sickle cell trait-associated renal medullary carcinoma","volume":"50","author":"Marino-Enriquez","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"R231-20230922","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2018.03.032","article-title":"Responses to alectinib in ALK-rearranged papillary renal cell carcinoma","volume":"74","author":"Pal","year":"2018","journal-title":"Eur Urol"},{"key":"R232-20230922","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/PAS.0000000000000179","article-title":"VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?","volume":"38","author":"Smith","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R233-20230922","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.prp.2016.07.004","article-title":"TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: report of a case with a TPM3-ALK translocation","volume":"212","author":"Thorner","year":"2016","journal-title":"Pathol Res Pract"},{"key":"R234-20230922","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/his.13185","article-title":"Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review","volume":"71","author":"Yu","year":"2017","journal-title":"Histopathology"},{"key":"R235-20230922","doi-asserted-by":"crossref","DOI":"10.1007\/s00428-020-02752-5","article-title":"ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology","author":"Hang","year":"2020","journal-title":"Virchows Arch"},{"key":"R236-20230922","first-page":"147","article-title":"Clear cell renal cell carcinoma with a poorly-differentiated component: a novel variant causing potential diagnostic difficulty","volume":"32","author":"Taneja","year":"2019","journal-title":"Mod Pathol"},{"key":"R237-20230922","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/modpathol.2016.133","article-title":"High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment","volume":"29","author":"Kouba","year":"2016","journal-title":"Mod Pathol"},{"key":"R238-20230922","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1476-4598-13-39","article-title":"Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy","volume":"13","author":"Wang","year":"2014","journal-title":"Mol Cancer"},{"key":"R239-20230922","article-title":"Mutations in renal cell carcinoma","author":"D\u2019Avella","year":"2018","journal-title":"Urol Oncol"},{"key":"R240-20230922","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1158\/1078-0432.CCR-15-2631","article-title":"Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with metastatic renal cell carcinoma","volume":"22","author":"Kwiatkowski","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R241-20230922","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071692","article-title":"Targeting the PD-1\/PD-L1 pathway in renal cell carcinoma","volume":"20","author":"Kammerer-Jacquet","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R242-20230922","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020565","article-title":"New first line treatment options of clear cell renal cell cancer patients with PD-1 or PD-L1 immune-checkpoint inhibitor-based combination therapies","volume":"9","author":"Grimm","year":"2020","journal-title":"J Clin Med"},{"key":"R243-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11934-019-0866-8","article-title":"A critical insight into the clinical translation of PD-1\/PD-L1 blockade therapy in clear cell renal cell carcinoma","volume":"20","author":"Nunes-Xavier","year":"2019","journal-title":"Curr Urol Rep"},{"key":"R244-20230922","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1158\/1078-0432.CCR-19-1135","article-title":"PD-L1 expression and clinical outcomes to cabozantinib, everolimus, and sunitinib in patients with metastatic renal cell carcinoma: analysis of the randomized clinical trials METEOR and CABOSUN","volume":"25","author":"Flaifel","year":"2019","journal-title":"Clin Cancer Res"},{"key":"R245-20230922","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1158\/2326-6066.CIR-17-0475","article-title":"The clinical activity of PD-1\/PD-L1 inhibitors in metastatic non-clear cell renal cell carcinoma","volume":"6","author":"McKay","year":"2018","journal-title":"Cancer Immunol Res"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T23:07:44Z","timestamp":1695424064000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001476"}},"subtitle":["III: Molecular Pathology of Kidney Cancer"],"short-title":[],"issued":{"date-parts":[[2020,4,3]]},"references-count":234,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001476","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,3]]}}}